acl, page-5

whimp!

I have gone overboard on it with eyes wide open.

You are right if GSK buy up to 5% without any notification.

The SPP has put the brakes on for this month but that is about to come off. It is a classic pennent formation with my next target around the 2.25-2.45 level maybe higher and probably after the final sign off on the pilot trial.

Unfortunately i agree with bioshares and this baby will probably never be seen paying a dividend due to taken over. All i can say is that it will not be cheap in my eyes...

ONly my thoughts and do your own research.